Claims
- 1. A compound of the formula ##STR29## wherein R.sub.1 and R.sub.2, together with the nitrogen atom to which they are attached, are di(alkyl of 1 to 3 carbon atoms)amino, N-(alkyl of 1 to 3 carbon atoms)-cyclohexylamino, (alkylene of 4 to 5 carbon atoms)-imino, (monomethyl-substituted alkylene of 4 to 5 carbon atoms)-imino, (dimethyl-substituted alkylene of 4 to 5 carbon atoms)-imino, 4-hydroxy-piperidino, piperid-4-on-1-yl, tetrahydropyridino, morpholino, thiomorpholino, N-methyl-piperazino, N-benzyl-piperazino, N-chlorophenyl-piperazino, hexamethyleneimino, heptamethyleneimino, octamethyleneimino, 3-aza-bicyclo[3,2,2]nonan-3-yl, 1,2,3,4-tetrahydro-isoquinolin-2-yl, 1,2,3,4,5,6,7,8-octahydro-isoquinolin-2-yl, decahydro-isoquinolin-2-yl, octahydroisoindol-2-yl or 8-aza-1,4-dioxa-spiro[4,5]decan-8-yl;
- R.sub.3 is hydrogen, fluorine, chlorine, bromine, iodine, methyl, hydroxyl, methoxy, benzyloxy, acetoxy, nitro, amino, acetylamino, methylsulfonylamino, benzoylamino, ethoxycarbonylamino, cyano, carboxyl, ethoxycarbonyl, aminocarbonyl or aminosulfonyl;
- R.sub.4 is hydrogen or methyl;
- R.sub.5 is hydrogen or, when W is carboxyl or (alkoxy of 1 to 4 carbon atoms) carbonyl, also chlorine;
- A is a single bond, dimethyl-methylene, ethylene, ##STR30## R.sub.6 and R.sub.7 are hydrogen or, together with the carbon atom to which they are attached, alkylidene of 2 to 5 carbon atoms, phenyl(alkylidene of 1 to 3 carbon atoms) or cyclohexylidene;
- R.sub.9 is hydrogen, alkyl of 1 to 5 carbon atoms, alkenyl of 3 to 5 carbon atoms, phenyl, halophenyl, methylphenyl, hydroxyphenyl, methoxyphenyl, benzyloxyphenyl, 4-methylmercaptophenyl, pyridyl, cyclohexyl, carboxyl, cyano, aminocarbonyl, methoxycarbonyl, ethoxycarbonyl, hydroxymethyl, methoxymethyl or phenyl(alkyl of 1 to 2 carbon atoms);
- B is methylene, ethylidene or ethylene; and
- W is methyl, hydroxymethyl, formyl, acetyl, carboxyl, cyano, 2-carboxy-ethenyl, 2-(alkoxy of 1 to 3 carbon atoms-carbonyl)-ethenyl, carboxy(alkyl of 1 to 2 carbon atoms), (alkoxy of 1 to 3 carbon atoms-carbonyl)-(alkyl of 1 to 2 carbon atoms), di(alkoxy of 1 to 3 carbon atoms-carbonyl)-(alkyl of 1 to 2 carbon atoms), (2,2-dimethyl-dioxolan-4-yl)methoxy-carbonyl, benzyloxy-carbonyl, aminocarbonyl, methylamino-carbonyl, dimethylaminocarbonyl, piperidino-carbonyl, morpholino-carbonyl, (alkoxy of 1 to 4 carbon atoms)-carbonyl; (mono- or dihydroxy-substituted alkoxy of 1 to 4 carbon atoms)-carbonyl, where individual methyl or methylene groups of the alkyl moiety are monohydroxy-substituted and the methylene group adjacent the oxygen atom is unsubstituted; or ##STR31## n is 2, 3 or 4; and R.sub.8 is methoxy, ethoxy, nicotinoyloxy, 1,3-dimethyl-xanthine-7-yl, dimethylamino or diethylamino;
- or a non-toxic, pharmacologically acceptable addition salt thereof.
- 2. A compound of claim 1, which is of the formula ##STR32## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, A, B and W have the meanings defined in claim 1,
- or a non-toxic, pharmaceutically acceptable addition salt thereof.
- 3. A compound of claim 2,
- wherein
- R.sub.1 and R.sub.2, together with the nitrogen atom to which they are attached, are dimethylamino, (alkylene of 4 to 5 carbon atoms)-imino, (monomethyl-substituted alkylene of 4 to 5 carbon atoms)-imino, (dimethyl-substituted alkylene of 4 to 5 carbon atoms)-imino, tetrahydropyridino, hexamethyleneimino, heptamethyleneimino, octamethyleneimino, or octahydro-isoindol-2-yl;
- R.sub.3 is hydrogen, fluorine, chlorine, methyl, or methoxy;
- R.sub.4 is hydrogen;
- R.sub.5 is hydrogen;
- A is ##STR33## R.sub.6 and R.sub.7 are hydrogen or, together with the carbon atom to which they are attached, alkylidene of 2 to 5 carbon atoms, phenyl(alkylidene of 1 to 3 carbon atoms) or cyclohexylidene;
- R.sub.9 is hydrogen, alkyl of 1 to 5 carbon atoms, alkenyl of 3 to 5 carbon atoms, phenyl, fluorophenyl, chlorophenyl, bromophenyl, methylphenyl, hydroxyphenyl, methoxyphenyl, benzyloxyphenyl, 4-methylmercaptophenyl, pyridyl, cyclohexyl, carboxyl, cyano, aminocarbonyl, methoxycarbonyl, ethoxycarbonyl, hydroxymethyl, methoxymethyl, or phenyl(alkyl of 1 to 2 carbon atoms);
- B is methylene; and
- W is methyl, hydroxymethyl, formyl, carboxyl, cyano, 2-carboxy-ethenyl, 2-(alkoxy of 1 to 3 carbon atoms-carbonyl)-ethenyl, 2-carboxy-ethyl, (alkoxy of 1 to 3 carbon atoms-carbonyl)-(alkyl of 1 to 2 carbon atoms), (2,2-dimethyl-dioxolan-4-yl)methoxy-carbonyl, (alkoxy of 1 to 4 carbon atoms)-carbonyl; (mono- or dihydroxy-substituted alkoxy of 1 to 4 carbon atoms)-carbonyl, where individual methyl or methylene groups of the alkyl moiety are monohydroxy-substituted and the methylene group adjacent the oxygen atom is unsubstituted; or ##STR34## where n is 2 or 3, and R.sub.8 is methoxy, diethylamino, nicotinoyloxy, or 1,3-dimethyl-xanthine-7-yl;
- or a non-toxic, pharmacologically acceptable addition salt thereof.
- 4. A compound of claim 3,
- where
- R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, A and B have the meanings defined in claim 40; and
- W is carboxyl; (alkoxy of 1 to 4 carbon atoms)-carbonyl; or (mono- or dihydroxy-substituted alkoxy of 1 to 4 carbon atoms)-carbonyl, where individual methyl or methylene groups of the alkyl moiety are monohydroxy-substituted and the methylene group adjacent the oxygen atom is unsubstituted;
- or a non-toxic, pharmacologically acceptable addition salt thereof.
- 5. A compound of claim 3,
- where
- R.sub.1 and R.sub.2, together with the nitrogen atom to which they are attached, are pyrrolidino, methyl-pyrrolidino, piperidino, methyl-piperidino, dimethylpiperidino, tetrahydropyridino or hexamethylene-imino;
- R.sub.3 is hydrogen, fluorine, chlorine, methyl or methoxy;
- R.sub.4 is hydrogen;
- R.sub.5 is hydrogen;
- A is ##STR35## R.sub.6 and R.sub.7 are hydrogen or, together with the carbon atom to which they are attached, alkylidene of 2 to 5 carbon atoms, phenyl(alkylidene of 1 to 3 carbon atoms) or cyclohexylidene;
- R.sub.9 is hydrogen, alkyl of 1 to 5 carbon atoms, phenyl, fluorophenyl, chlorophenyl, methylphenyl, or pyridyl;
- B is methylene; and
- W is methyl, hydroxymethyl, formyl, carboxyl, cyano, 2-carboxy-ethenyl, 2-(alkoxy of 1 to 3 carbon atoms-carbonyl)-ethenyl, 2-carboxy-ethyl, (alkoxy of 1 to 3 carbon atoms-carbonyl)-(alkyl of 1 to 2 carbon atoms), (2,2-dimethyl-dioxolan-4-yl)-methoxy-carbonyl, (alkoxy of 1 to 4 carbon atoms)-carbonyl; (mono- or dihydroxy-substituted alkoxy of 1 to 4 carbon atoms)-carbonyl, where individual methyl or methylene groups of the alkyl moiety are monohydroxy-substituted and the methylene group adjacent the oxygen atom is unsubstituted;
- or a non-toxic, pharmacologically acceptable addition salt thereof.
- 6. A compound of claim 5,
- where
- R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, A and B have the meanings defined in claim 5, and
- W is carboxyl or (alkoxy of 1 to 4 carbon atoms)-carbonyl;
- or a non-toxic, pharmacologically acceptable addition salt thereof.
- 7. A compound of claim 6,
- where
- R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and B have the meanings defined in claim 6;
- A is methyl-methylene, ethyl-methylene, n-propyl-methylene, n-butyl-methylene or phenyl-methylene; and
- W is carboxyl;
- or a non-toxic, pharmacologically acceptable addition salt thereof.
- 8. A compound of claim 1, which is 4-[(1-(2-piperidino-phenyl)-1-ethyl)-aminocarbonylmethyl]-benzoic acid, an alkyl of 1 to 3 carbon atoms ester thereof or a non-toxic, pharmaceutically acceptable addition salt thereof.
- 9. A compound of claim 1, which is 4-[(2-piperidinobenzhydryl)-aminocarbonylmethyl]-benzoic acid, an alkyl of 1 to 3 carbon atoms ester thereof or a non-toxic, pharmaceutically acceptable addition salt thereof.
- 10. A compound of claim 1, which is 4-[(1-(2-piperidino-phenyl)-1-butyl)-aminocarbonylmethyl]-benzoic acid, an alkyl of 1 to 3 carbon atoms ester thereof or a non-toxic, pharmaceutically acceptable addition salt thereof.
- 11. A hypoglycemic pharmaceutical composition consisting essentially of an inert pharmaceutical carrier and an effective hypoglycemic amount of a compound of claim 1.
- 12. The method of lowering the blood sugar level in a warm-blooded animal host in need thereof, which comprises perorally or parenterally administering to said host an effective hypoglycemic amount of a compound of claim 1.
- 13. A hypoglycemic pharmaceutical composition consisting essentially of an inert pharmaceutical carrier and an effective hypoglycemic amount of a compound of claim 3.
- 14. The method of lowering the blood sugar level in a warm-blooded animal host in need thereof, which comprises perorally or parenterally administering to said host an effective hypoglycemic amount of a compound of claim 3.
- 15. A hypoglycemic pharmaceutical composition consisting essentially of an inert pharmaceutical carrier and an effective hypoglycemic amount of a compound of claim 7.
- 16. The method of lowering the blood sugar level in a warm-blooded animal host in need thereof, which comprises perorally or parenterally administering to said host an effective hypoglycemic amount of a compound of claim 7.
Priority Claims (3)
Number |
Date |
Country |
Kind |
3100575 |
Jan 1981 |
DEX |
|
3225155 |
Jul 1982 |
DEX |
|
3225188 |
Jul 1982 |
DEX |
|
Parent Case Info
This is a continuation of copending application Ser. No. 510,071, filed June 30, 1983, now abandoned; which in turn is a continuation-in-part of application Ser. No. 335,565, filed Dec. 29, 1981, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4172947 |
Warner et al. |
Oct 1979 |
|
4186199 |
Glamkowski et al. |
Jan 1980 |
|
Foreign Referenced Citations (4)
Number |
Date |
Country |
764,238 |
Sep 1971 |
BEX |
0058779 |
Sep 1982 |
EPX |
2225165 |
Nov 1974 |
FRX |
2370723 |
Jun 1978 |
FRX |
Continuations (1)
|
Number |
Date |
Country |
Parent |
510071 |
Jun 1983 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
335565 |
Dec 1981 |
|